Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Saag

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Positively Aware : the Monthly Journal of the Test Positive Aware Network|June 30, 2011
The ghosts of Christmas past. How would those we've lost guide us today?Michael Saag
Annals of Internal Medicine|July 16, 2003
Is it time to proactively switch successful antiretroviral therapy? Carefully check your SWATCHMichael Saag
Physiological Reviews|April 21, 2022
Wonder of wonders, miracle of miracles: the unprecedented speed of COVID-19 scienceMichael Saag
AIDS (London, England)|September 5, 2020
Special section: COVID-19 among people living with HIVMichael Saag
Current Opinion in HIV and AIDS|October 9, 2013
The antiretroviral drug pipeline: prospects and implications for future treatment researchCharles Flexner, Michael Saag
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2010
How do HIV elite controllers do what they do?Michael Saag, Steven G Deeks
AIDS Research and Human Retroviruses|May 30, 2008
An open-label safety study of enfuvirtide injection with a needle-free injection device or needle/syringe: the Biojector 2000 Open-label Safety Study (BOSS)Jacob P Lalezari, Michael Saag, Charles Walworth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2015
Immunization costs and programmatic barriers at an urban HIV clinicEllen F Eaton, Andrzej Kulczycki, Michael Saag, et al.
AIDS (London, England)|April 19, 2016
Cost considerations in the current antiretroviral eraEllen F Eaton, Ashutosh Tamhane, Michael Saag, et al.
AIDS and Behavior|October 22, 2015
Factors Associated with Prescription of Opioids and Co-prescription of Sedating Medications in Individuals with HIVJessica S Merlin, Ashutosh Tamhane, Joanna L Starrels, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Positively Aware : the Monthly Journal of the Test Positive Aware Network|June 30, 2011
The ghosts of Christmas past. How would those we've lost guide us today?Michael Saag
Annals of Internal Medicine|July 16, 2003
Is it time to proactively switch successful antiretroviral therapy? Carefully check your SWATCHMichael Saag
Physiological Reviews|April 21, 2022
Wonder of wonders, miracle of miracles: the unprecedented speed of COVID-19 scienceMichael Saag
AIDS (London, England)|September 5, 2020
Special section: COVID-19 among people living with HIVMichael Saag
Current Opinion in HIV and AIDS|October 9, 2013
The antiretroviral drug pipeline: prospects and implications for future treatment researchCharles Flexner, Michael Saag
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2010
How do HIV elite controllers do what they do?Michael Saag, Steven G Deeks
AIDS Research and Human Retroviruses|May 30, 2008
An open-label safety study of enfuvirtide injection with a needle-free injection device or needle/syringe: the Biojector 2000 Open-label Safety Study (BOSS)Jacob P Lalezari, Michael Saag, Charles Walworth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2015
Immunization costs and programmatic barriers at an urban HIV clinicEllen F Eaton, Andrzej Kulczycki, Michael Saag, et al.
AIDS (London, England)|April 19, 2016
Cost considerations in the current antiretroviral eraEllen F Eaton, Ashutosh Tamhane, Michael Saag, et al.
AIDS and Behavior|October 22, 2015
Factors Associated with Prescription of Opioids and Co-prescription of Sedating Medications in Individuals with HIVJessica S Merlin, Ashutosh Tamhane, Joanna L Starrels, et al.
Pageof 9